lorazepam has been researched along with Disease Exacerbation in 5 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Once the clinical diagnosis of Alzheimer's disease has been made, a treatment plan must be developed." | 2.41 | Guidelines for managing Alzheimer's disease: Part II. Treatment. ( Cherry, D; Cummings, JL; Frank, JC; Hewett, L; Kemp, B; Kohatsu, ND; Mittman, B, 2002) |
| " Our objective was to evaluate BZD dosing in SE patients and its effects on clinical/electrographic outcomes." | 1.48 | Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. ( Ibrahim, M; Mahulikar, A; Mohamed, W; Rao, SK; Seraji-Bozorgzad, N; Shah, A, 2018) |
| "Delirium is still one of the most common and distressing symptoms in palliative care patients." | 1.38 | Reversible delirium in an advanced cancer patient. ( Jagsch, C; Kierner, KA; Watzke, HH, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, SK | 1 |
| Mahulikar, A | 1 |
| Ibrahim, M | 1 |
| Shah, A | 1 |
| Seraji-Bozorgzad, N | 1 |
| Mohamed, W | 1 |
| Kierner, KA | 1 |
| Jagsch, C | 1 |
| Watzke, HH | 1 |
| Singh, D | 1 |
| Forlano, R | 1 |
| Athey, R | 1 |
| Dhossche, D | 1 |
| Cummings, JL | 1 |
| Frank, JC | 1 |
| Cherry, D | 1 |
| Kohatsu, ND | 1 |
| Kemp, B | 1 |
| Hewett, L | 1 |
| Mittman, B | 1 |
1 review available for lorazepam and Disease Exacerbation
| Article | Year |
|---|---|
Guidelines for managing Alzheimer's disease: Part II. Treatment.
Topics: Advance Directives; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Disease Progression; D | 2002 |
4 other studies available for lorazepam and Disease Exacerbation
| Article | Year |
|---|---|
Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
Topics: Adult; Aged; Anticonvulsants; Benzodiazepines; Coma; Disease Progression; Drug Resistant Epilepsy; F | 2018 |
Reversible delirium in an advanced cancer patient.
Topics: Amines; Analgesics; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, No | 2012 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Choline | 2008 |
Brief report: catatonia in autistic disorders.
Topics: Adolescent; Anti-Anxiety Agents; Autistic Disorder; Catatonia; Disease Progression; Humans; Lorazepa | 1998 |